About Aclipse Therapeutics

About company

Aclipse Therapeutics is an innovative biopharmaceutical company focusing on developing novel and highly differentiated drugs to address diseases with high unmet medical needs. The company's strategy is reducing clinical development risk by combining a new and druggable understanding of disease pathways with a novel form of an existing drug that inhibits these pathways, allowing to build upon existing nonclinical and clinical data while creating a significant patent barrier-to-entry. Founded in 2017, Aclipse Therapeutics is headquartered in Radnor, Pennsylvania.